Rite Aid (RAD) Earning Somewhat Positive News Coverage, Report Finds

Headlines about Rite Aid (NYSE:RAD) have trended somewhat positive on Thursday, according to Accern. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rite Aid earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 43.7945956918714 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the headlines that may have effected Accern’s rankings:

Shares of Rite Aid (NYSE:RAD) opened at $2.05 on Thursday. The firm has a market cap of $2,190.00, a P/E ratio of 18.64 and a beta of 1.76. The company has a current ratio of 0.86, a quick ratio of 0.59 and a debt-to-equity ratio of 3.66. Rite Aid has a 1 year low of $1.38 and a 1 year high of $6.15.

RAD has been the subject of a number of analyst reports. Zacks Investment Research raised shares of Rite Aid from a “sell” rating to a “hold” rating in a research note on Friday, November 17th. Vetr raised shares of Rite Aid from a “hold” rating to a “strong-buy” rating and set a $2.54 target price for the company in a research note on Tuesday, January 16th. Deutsche Bank initiated coverage on shares of Rite Aid in a research note on Monday, December 4th. They set a “hold” rating and a $2.25 target price for the company. Royal Bank of Canada set a $2.00 target price on shares of Rite Aid and gave the company a “hold” rating in a research note on Wednesday, October 25th. Finally, Evercore ISI initiated coverage on shares of Rite Aid in a research note on Thursday, January 4th. They set an “underperform” rating and a $1.50 target price for the company. Two analysts have rated the stock with a sell rating, six have assigned a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. Rite Aid has a consensus rating of “Hold” and an average target price of $2.75.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Week Herald and is the sole property of of Week Herald. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://weekherald.com/2018/02/15/rite-aid-rad-earning-somewhat-positive-news-coverage-report-finds.html.

About Rite Aid

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.

Insider Buying and Selling by Quarter for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply